whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes

March 2008

A recent JAMA study has people asking whether abruptly stopping clopidogrel (Plavix) can worsen cardiovascular outcomes.

Acute coronary syndrome patients seem to have about twice the risk of death or heart attack within 90 days of stopping clopidogrel.

Researchers speculate it's a possible "rebound effect."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote